In a significant development that underlines the increasing importance of gene therapy in addressing genetic disorders, Sarepta’s gene therapy has been bolstered with an FDA platform designation. This milestone not only highlights the regulatory recognition and support for this groundbreaking treatment approach but also underscores the ongoing transformation of the genetic medicine landscape. The FDA […]